This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Common Data Elements (CDE) | |
|---|---|
| Name | Common Data Elements |
| Abbreviation | CDE |
| Type | Metadata standard |
| Introduced | 1990s |
| Developer | International initiatives, national institutes |
| Domain | Clinical research, biomedical research, health informatics |
Common Data Elements (CDE) are standardized, precisely defined units of information created to enable consistent data capture, exchange, and aggregation across studies, trials, and systems. They serve to harmonize variable names, permissible values, and metadata so that datasets collected by organizations such as the National Institutes of Health, World Health Organization, European Commission, Bill & Melinda Gates Foundation, and Wellcome Trust can be compared, combined, and reused across projects associated with institutions like Johns Hopkins University, Mayo Clinic, Harvard University, and Massachusetts General Hospital.
CDE are defined as interoperable metadata specifications that include variable names, definitions, data types, and value sets used by consortia such as the Clinical Data Interchange Standards Consortium and programs supported by agencies like the National Cancer Institute, National Institute of Neurological Disorders and Stroke, European Medicines Agency, Centers for Disease Control and Prevention, and philanthropic initiatives led by the Rockefeller Foundation. Their purpose aligns with goals pursued by projects at IBM Research, Microsoft Research, Google Health, Apple Health, and academic centers including Stanford University and University of Oxford to reduce redundancy in data collection, accelerate meta-analysis, and support regulatory submissions to bodies like the U.S. Food and Drug Administration and European Commission. CDE facilitate collaboration among consortia such as the Human Genome Project, Cancer Genome Atlas, All of Us Research Program, Global Alliance for Genomics and Health, and multi-site trials run by networks like EORTC and NIHR.
Origins trace to standardization efforts in the 1990s by organizations including World Health Organization, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and national programs at National Institutes of Health and Centers for Disease Control and Prevention. Major milestones involved initiatives by the National Cancer Institute with its caBIG program, collaborations with European Commission research frameworks, and harmonization activities led by consortia such as Clinical Data Interchange Standards Consortium and the Global Alliance for Genomics and Health. Influential events and reports from institutions like Institute of Medicine, Royal Society, Bodleian Libraries, National Academy of Sciences, and funders including the Wellcome Trust and Bill & Melinda Gates Foundation shaped adoption across networks such as Horizon 2020 and NIH Big Data to Knowledge (BD2K).
A CDE typically comprises a unique identifier, variable name, plain-language definition, data type (e.g., integer, string, coded value), permissible values with controlled vocabularies, and provenance metadata pointing to organizations such as SNOMED International, LOINC Committee, International Classification of Diseases, American Medical Association, and standards houses like ISO and IEEE. Component mapping often references ontologies developed at institutions like Broad Institute, Stanford Center for Biomedical Informatics Research, and European Bioinformatics Institute while aligning with repositories maintained by National Library of Medicine, PubMed Central, and platforms such as GitHub and Zenodo for version control and persistent identifiers.
Interoperability depends on harmonizing CDE with standards from HL7 International, including FHIR, and terminologies such as SNOMED CT, LOINC, and ICD-10. Regulatory and standards convergence involves agencies and groups like the Food and Drug Administration, European Medicines Agency, Clinical Data Interchange Standards Consortium, and international bodies such as ISO and World Health Organization. Implementations often integrate with infrastructures supported by Amazon Web Services, Google Cloud Platform, Microsoft Azure, and research platforms from Oracle Health Sciences and IBM Watson Health, ensuring compatibility with data-sharing frameworks used by projects like All of Us Research Program and Human Cell Atlas.
CDE are applied in clinical trials run by sponsors such as Pfizer, Roche, Novartis, and Johnson & Johnson, cohort studies at Framingham Heart Study, surveillance programs by Centers for Disease Control and Prevention and Public Health England, large-scale genomics initiatives like the 1000 Genomes Project and International Cancer Genome Consortium, and registries maintained by organizations including American Heart Association and American Cancer Society. Health systems such as Kaiser Permanente and research hospitals including Cleveland Clinic implement CDE to enable cross-site audits, pooled analyses, and regulatory submissions to FDA and health technology assessment agencies like NICE.
Governance models vary: centralized registries operated by national agencies like the National Institutes of Health, distributed stewardship by consortia such as the Global Alliance for Genomics and Health, and community-driven curation hosted by institutions like European Bioinformatics Institute and National Library of Medicine. Maintenance processes echo practices from organizations including ISO, IEEE, HL7 International, and funder policies from Wellcome Trust and Bill & Melinda Gates Foundation, with versioning, change control, and stakeholder review drawing on advisory bodies such as the Institute of Medicine and editorial boards at universities and research institutes.
Critiques arise from stakeholders including academic centers like Harvard University and University of Cambridge and industry players such as Pfizer and GlaxoSmithKline about rigidity, implementation cost, and potential stifling of innovation. Technical barriers involve mapping to legacy systems at hospitals such as Mayo Clinic and Massachusetts General Hospital, reconciliation with diverse standards maintained by SNOMED International and LOINC Committee, and governance tensions between funders like NIH and international regulators including European Medicines Agency. Ethical and legal concerns noted by commentators at Amnesty International and legal scholars in courts and legislatures such as the European Court of Human Rights and United States Congress focus on data privacy, consent, and cross-border data sharing.
Category:Data standards